Swiss healthcare company ForaCare Suisse AG on Thursday reported the availability of its Swissmedic approved FORA COVID-19 Antigen Rapid Test, with fast, accurate and easy-to-interpret test results developed via a collaboration with Taiwan Academia Sinica.

The company added that the FORA COVID-19 Antigen Rapid Test has been approved for distribution in Switzerland and its treaty countries without restriction. It is listed by the Federal Institute for Drugs and Medical Devices (BfArM) and is reimbursable in Germany.

This diagnostic FORA COVID-19 antigen test is for the direct detection of an acute infection with SARS-CoV-2, the respiratory virus caused by the novel coronavirus. The company's test can be administered by trained professionals and doesn't rely on laboratory-processing.

In conjunction, the recent clinical study results demonstrated the FORA COVID-19 Rapid Test is accurate and reliable with a 95.8% sensitivity and a 98.6% specificity by testing 57 PCR-positive and 80 PCR-negative specimens. The test kit packaging can determine if a person has an active COVID-19 infection. The test provides accurate results in 15 minutes, concluded the company.